Theravance Biopharma (TBPH) Long-Term Debt Issuances (2020)
Theravance Biopharma (TBPH) posted Long-Term Debt Issuances of $380 million for FY2020.
Powered by 
Analysis
Theravance Biopharma (TBPH) Long-Term Debt Issuances (2020) Analysis & Trends
- Annual Long-Term Debt Issuances shows a four-year compound annual growth rate of 14.3% (FY2016 to FY2020).
- Business Quant data shows TBPH's Long-Term Debt Issuances at $229.44 million in FY2018 and $222.5 million in FY2016.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | LT Debt Issuance (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.06 Bn | 1,133.65 Bn | 19.71 Bn | 8.94 Bn |
| 2 | Johnson & Johnson | 643.87 Bn | 563.73 Bn | 17.30 Bn | - |
| 3 | AbbVie | 501.19 Bn | 474.31 Bn | 12.70 Bn | - |
| 4 | Merck | 357.68 Bn | 312.06 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 301.88 Bn | 265.87 Bn | 11.24 Bn | 1.98 Bn |
| 6 | Astrazeneca | 267.25 Bn | 240.94 Bn | 12.86 Bn | - |
| 7 | Amgen | 241.08 Bn | 196.48 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 192.57 Bn | 166.76 Bn | 6.22 Bn | - |
| 9 | Pfizer | 171.48 Bn | 118.13 Bn | 10.94 Bn | - |
| 10 | Theravance Biopharma | 883.70 Mn | -543.66 Mn | - | - |
API Access
Theravance Biopharma Long-Term Debt Issuances API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=TBPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-debt-issuances", "ticker": "TBPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=TBPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();